Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-20

FDA Approved: EXEMESTANE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved the original ANDA for Exemestane from Aurobindo Pharma Limited, establishing a generic aromatase inhibitor. It relates to treatment of breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exemestane (Exemestane)

Snippet

ORIG AP for EXEMESTANE (EXEMESTANE)